DIS vs VRTV: Which Is the Better Buy?

Side-by-side comparison of The Walt Disney Company and Veritiv Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-24.
The Walt Disney Company Β· Communication Services
$103.49
+32.3% upside to fair value
Med Conviction Grade B High Quality
VS
Veritiv Corporation Β· Industrials
$169.99
-45.0% upside to fair value
Med Conviction Grade D
QuantHub Verdict
DIS has more upside to fair value (+32.3%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric DIS VRTV
Current Price $103.49 $169.99
Fair Value Estimate $136.94 $93.49
Upside to Fair Value +32.3% -45.0%
Market Cap $179.7B $2.3B
Forward P/E β€” β€”
EV / EBITDA 9.5x 5.4x
Price / Sales 1.8x 0.4x
Price / FCF 21.7x 10.4x
Revenue Growth YoY +6.8% -19.0%
Gross Margin 37.6% 22.7%
Operating Margin 16.0% 5.9%
Return on Equity 7.9% 48.6%
Dividend Yield 1.45% 1.48%
FCF Yield 4.61% 9.57%
Analyst Consensus Strong Buy Hold
Investment Thesis
DIS β€” The Walt Disney Company
The Walt Disney Company operates a global entertainment empire spanning two primary divisions: Disney Media and Entertainment Distribution, which houses the ABC, ESPN, Disney, Freeform, FX, Fox, National Geographic and Star networks along with the Walt Disney Pictures, Twentieth Century Studios, Marvel, Lucasfilm, Pixar and Searchlight Pictures studios and the Disney+, Disney+ Hotstar, ESPN+, Hul…
VRTV β€” Veritiv Corporation
Veritiv Corporation is a business-to-business distributor of specialty packaging, facility solutions, print, and publishing products, operating through four segments with a network of distribution centers and roughly 5,000 employees. The business quality is mixed: it generates a strong 48.6% ROE and trades at a low 7.13 trailing P/E and 5.44 EV/EBITDA, but revenue declined 19.0% year over year in…
Accumulation Zones
Metric DIS VRTV
Zone Low $102.70 $70.12
Zone High $116.40 $79.47
In Buy Zone? Yes No
← DIS Research    VRTV Research β†’    All Research